Werewolf Therapeutics, Inc. Common Stock HOWL
i
Market datapartial · fetched 2026-11-03T14:42:42.937Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T14:36:55.76102271Z
FundamentalsAlpha Vantage · unavailable
Werewolf Therapeutics, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 6.40 | 550.8% | 516.4% | 0.69 | 474.1% | 51.0% |
| 25Δ | 5.96 | 585.9% | 477.8% | 0.79 | 403.3% | 42.2% |
| 30Δ | 5.52 | 621.0% | 439.2% | 0.89 | 332.4% | 33.3% |
| 35Δ | 5.09 | 656.1% | 400.6% | 1.00 | 261.6% | 24.5% |
| 40Δ | 2.77 | 521.0% | 181.8% | 1.05 | 247.9% | 21.9% |
| 45Δ | 1.85 | 425.3% | 95.0% | 1.11 | 236.5% | 19.6% |
| 50Δ | 1.16 | 225.2% | 17.2% | |||
| 55Δ | 1.22 | 213.9% | 14.9% | |||
| 60Δ | 1.27 | 202.5% | 12.5% | |||
| 65Δ | 1.33 | 191.2% | 10.2% | |||
| 70Δ | 1.38 | 179.8% | 7.8% | |||
| 75Δ | 1.44 | 168.5% | 5.5% | |||
| 80Δ | 1.49 | 157.2% | 3.1% | |||
20Δ
- Pseudo strike
- 6.40
- IV
- 550.8%
- B/E move
- 516.4%
- Pseudo strike
- 0.69
- IV
- 474.1%
- B/E move
- 51.0%
25Δ
- Pseudo strike
- 5.96
- IV
- 585.9%
- B/E move
- 477.8%
- Pseudo strike
- 0.79
- IV
- 403.3%
- B/E move
- 42.2%
30Δ
- Pseudo strike
- 5.52
- IV
- 621.0%
- B/E move
- 439.2%
- Pseudo strike
- 0.89
- IV
- 332.4%
- B/E move
- 33.3%
35Δ
- Pseudo strike
- 5.09
- IV
- 656.1%
- B/E move
- 400.6%
- Pseudo strike
- 1.00
- IV
- 261.6%
- B/E move
- 24.5%
40Δ
- Pseudo strike
- 2.77
- IV
- 521.0%
- B/E move
- 181.8%
- Pseudo strike
- 1.05
- IV
- 247.9%
- B/E move
- 21.9%
45Δ
- Pseudo strike
- 1.85
- IV
- 425.3%
- B/E move
- 95.0%
- Pseudo strike
- 1.11
- IV
- 236.5%
- B/E move
- 19.6%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.16
- IV
- 225.2%
- B/E move
- 17.2%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.22
- IV
- 213.9%
- B/E move
- 14.9%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.27
- IV
- 202.5%
- B/E move
- 12.5%
65Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.33
- IV
- 191.2%
- B/E move
- 10.2%
70Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.38
- IV
- 179.8%
- B/E move
- 7.8%
75Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.44
- IV
- 168.5%
- B/E move
- 5.5%
80Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.49
- IV
- 157.2%
- B/E move
- 3.1%
Options history
Table
| Date | IV (%) |
|---|---|
| 242.07% | |
| 233.87% | |
| 264.98% | |
| 248.75% | |
| 386.20% | |
| 245.07% | |
| 223.11% | |
| 226.34% | |
| 263.15% | |
| 296.30% | |
| 195.77% | |
| 267.70% | |
| 272.27% | |
| 286.21% | |
| 168.37% | |
| 305.79% | |
| 278.38% | |
| 233.88% | |
| 289.28% | |
| 279.05% | |
| 297.09% |
Biotechnology
HRMY
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and markets therapies for patients with rare neurological disorders. The company is…
More →HUMA
Humacyte Inc (HUMA) is a groundbreaking biotechnology firm at the forefront of vascular and regenerative medicine, specializing in the development of human acellular vessels…
More →IBRX
ImmunityBio, Inc., an immunotherapy company, develops a memory T-cell cancer vaccine to fight multiple types of tumors without the use of high-dose chemotherapy.
More →IDYA
IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality, is focused on the discovery and development of targeted therapies for selected…
More →IFRX
Description unavailable
More →IGC
India Globalization Capital, Inc. buys and resells physical infrastructure commodities. The company is headquartered in Potomac, Maryland.
More →